Vaccine hesitancy among healthcare workers in Europe became a growing concern: doubts about effectiveness and safety, misbeliefs.

A new feasibility study that looked at a sustainable economic model for vaccine R&D infrastructure demonstrates that they could have a...

EU-funded CAPTIVATE project has the mission to create a next-generation malaria vaccine.

New clinical trial in Burkina Faso assessed the safety and immunogenicity of the BK-SE36/CpG malaria vaccine in healthy adults and children.

October 2, 2023 In a significant stride toward combatting malaria and Neglected Tropical Diseases (NTDs), the Global Health Innovative...

July 2023 The TRANSAVC2 project concluded with its final meeting, which took place in a hybrid format on April 19-20, 2023, in Brussels....

26 June 2023 On 29-31 May 2023, European Vaccine Initiative (EVI) in collaboration with Uganda Virus Research Institute-International...

Over the next 4 years, the UltiMalVax consortium will work to develop the ultimate vaccine for malaria elimination. This would be a...

Over the next 5 years, the NOSEVAC consortium will work intensively to create nasal vaccines targeting S. pneumoniae and B. pertussis...

07 June 2023 A Collaborative Vision: A new article highlighting the efforts to establish a robust vaccine research and development (R&D)...

27 April 2023 Malaria remains a major health challenge, particularly in sub-Saharan Africa, where children under five face the greatest...

On April 25th, we celebrate World Malaria Day and reflect on the progress that has been made in the fight against malaria. This year's theme

23-30 April 2023 The World Immunization Week (WIW), running from 24-30 April and European Immunization Week (EIW), running from 23-29...

March 2023 Written by the leishmaniasis team at the European Vaccine Initiative (EVI), an article entitled “Leishmaniasis — a Forgotten...

February 11, 2023 The International Day of Women and Girls in Science is celebrated to acknowledge the achievements of women in science...

NTDs are often overlooked and neglected due to their prevalence in low-income countries and the lack of resources available to combat them.

SEmalvac: new study demonstrates that antibody response to BK-SE36 vaccination is not impacted by African-specific SERA5 polymorphisms.

The International Day of Epidemic Preparedness recognises the importance of being prepared for, and responding to, public health emergencies

The Netherlands Enterprise Agency awarded 17 Mio Euro to EVI. This is part of the Product Development Partnerships IV Fund.

The WHO/TDR Clinical Research & Development Fellowships alumni meeting was held in Cape Town.

Fighting diseases of poverty & preventing emerging infections with vaccines - Joint film by EVI, GSK, iBET, Moderna and Vaccines Europe.

The latest results from two projects coordinated by EVI will be presented at the VASE conference 2022 to be held in Washington.

The World Antimicrobial Awareness Week (WAAW) occurs every year between 18 and 24 November.

Plasmodium falciparum is a highly complex pathogen that causes malaria. Protective malaria vaccine approaches can target three...